| Emma Enrica Warns, PA-C | |
|
214 W Bowery St, Akron, OH 44308-1046 | |
| (330) 543-1000 | |
| Not Available |
| Full Name | Emma Enrica Warns |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 214 W Bowery St, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053096529 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 50.008363RX (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emma Enrica Warns, PA-C 121 W Elm St, Kent, OH 44240-3711 Ph: (614) 753-6186 | Emma Enrica Warns, PA-C 214 W Bowery St, Akron, OH 44308-1046 Ph: (330) 543-1000 |
News Archive
One of the main obstacles to successfully treating breast cancer is the cells' ability to change in ways that make them resistant to treatment.
Extremely obese children have a 40 percent higher risk of gastroesophageal reflux disease and children who are moderately obese have a 30 percent higher risk of GERD compared to normal weight children, according to a Kaiser Permanente study published online in the International Journal of Pediatric Obesity.
A surgically implanted neuroprosthesis—programmed to stimulate coordinated activity of hip, knee, and ankle muscles—has led to substantial improvement in walking speed and distance in a patient with limited mobility after a stroke, according to a single-patient study in the American Journal of Physical Medicine & Rehabilitation, the official journal of the Association of Academic Physiatrists.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
› Verified 6 days ago
Margaret S Sfiligoj, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-9634 Fax: 330-375-3769 | |
Brittany Johnson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1622 E Turkeyfoot Lake Rd Ste 201, Akron, OH 44312 Phone: 330-776-4444 Fax: 330-776-4449 | |
Brittany Conner, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3975 Embassy Pkwy, Akron, OH 44333 Phone: 330-670-4242 | |
Mrs. Lara Renee Young, P.A.-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 150 Cross St, Akron, OH 44311 Phone: 330-996-9141 | |
Mr. Kodi Veale, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3975 Embassy Pkwy, Akron, OH 44333 Phone: 330-668-4040 Fax: 330-668-4078 | |
Eric Bendel, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 | |
Christy A. Mackay, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 1 Park West Blvd, Suite 200, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-865-6011 |